United Health Products Provides Business Update
October 07, 2021 07:00 ET
|
United Health products, Inc.
HENDERSON, Nev., Oct. 07, 2021 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTCPK: UEEC), (UHP), developer, manufacturer and marketer of HemoStyp™, a patented Neutralized Oxidized Regenerated...
Global $4.25+ Billion Hemostasis Diagnostic Devices and Equipment Markets, 2015-2020, 2020-2025F, 2030F - Major Players are C.R. Bard, Baxter Int'l., Pfizer, Johnson & Johnson, and Abbott Laboratories
June 28, 2021 04:08 ET
|
Research and Markets
Dublin, June 28, 2021 (GLOBE NEWSWIRE) -- The "Hemostasis Diagnostic Devices and Equipment Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to...
Global Hemostasis Diagnostics Market Report 2020 Featuring Market Leaders - Abbott, Thermo Fisher Scientific, F. Hoffmann-La Roche, Nihon Kohden, Sysmex, Siemens, Danaher, Grifols
January 06, 2021 10:08 ET
|
Research and Markets
Dublin, Jan. 06, 2021 (GLOBE NEWSWIRE) -- The "Hemostasis Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" report has been added to...
Hemostasis Analyzers Market To Reach USD 6,304.1 Million By 2026 | Reports And Data
November 18, 2019 10:40 ET
|
Reports and Data
New York, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Increasing prevalence of cardiovascular and blood-related disorders, growing geriatric population, and increasing laboratory automation are key factors...
Global Surgical Glue Market To Reach USD 7.89 Billion By 2026 | Reports And Data
May 08, 2019 11:08 ET
|
Reports And Data
The technological advancements in the healthcare industry, as well as the increase in the aged population, are influencing the market growth. Market Size – USD 4.09 Billion in 2018, Market Growth -...
Akers Biosciences Signs US Distribution Agreement with Diagnostica Stago
March 26, 2018 07:00 ET
|
Akers Biosciences Inc
THOROFARE, N.J., March 26, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, has...
Arch Therapeutics Announces 510(k) Submission to the U.S. FDA for AC5(TM) Topical Gel
July 25, 2017 07:55 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, MA--(Marketwired - Jul 25, 2017) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, today...
Arch Therapeutics Presents Corporate Update at the LD Micro Invitational on Tuesday, June 6, 2017
June 06, 2017 12:25 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, MA--(Marketwired - Jun 6, 2017) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, today...
Arch Therapeutics to Provide Corporate Update at the LD Micro Invitational on Tuesday, June 6, 2017
May 22, 2017 07:57 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, MA--(Marketwired - May 22, 2017) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be...
Arch Therapeutics to Provide Corporate Update at the 29th Annual Roth Conference on Monday, March 13, 2017
March 06, 2017 07:57 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, MA--(Marketwired - Mar 6, 2017) - Terrence Norchi, MD, CEO of Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and...